Clin2
NCT06251232Possibly a fitNot yet recruiting

Prednisone for drug-induced liver injury

HepatotoxicityIdiosyncratic Drug EffectPrednisone

Treatments studied

Part of Digestive system clinical trials.

This study tests whether prednisone, a steroid that reduces inflammation, can help people with severe liver injury caused by a medication. It might help if your liver tests are still high even after stopping the medicine that caused the problem.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • A doctor has confirmed that a medication damaged your liver.
  • Your liver tests show moderate to severe damage (AST or ALT at least 5 times the normal limit and bilirubin at least 2.5 mg/dL).
  • Your liver tests are not improving within 5–10 days after stopping the medication that caused the damage.
  • You are not already taking steroids or other drugs that suppress the immune system.
  • You are not pregnant or breastfeeding, and you do not have hepatitis B, hepatitis C, HIV, or an active infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06922669Recruiting
Steroids for drug-induced liver injury with high bilirubin

This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.

Shenyang, Liaoning
NCT05901519Recruiting· Phase 2
Prednisone to protect the liver during focused radiation for liver cancer

This trial tests whether prednisone (an anti-inflammatory steroid) can help protect the liver in people with hepatocellular carcinoma who are getting stereotactic body radiation therapy. It may reduce liver stress from radiation and help you tolerate treatment safely.

Ann Arbor, Michigan
NCT07167251Recruiting
Low-dose steroids for immunotherapy-related liver inflammation

This trial tests whether using low-dose steroids can safely manage liver inflammation caused by immunotherapy. It may help patients who have moderate liver problems from their cancer treatment but haven't yet started high-dose steroids.

Basel, Canton of Basel-City
NCT06797011Not yet recruiting· Phase 2/Phase 3
Plasma exchange for drug-induced liver injury with chronic liver disease

This trial tests whether a treatment called plasmapheresis (plasma exchange) can help people with severe liver damage caused by medications when they also have chronic liver disease. The treatment filters the blood to remove harmful substances, which may improve liver function and recovery.

New Delhi, National Capital Territory of Delhi
NCT07830901Not yet recruiting
Rates and outcomes of medication-caused liver damage

This study is looking at how often drug-induced liver injury occurs and how it affects patients over time. If you join, researchers will track your health to learn more about recovery and long-term outcomes.

NCT05012033Recruiting
Study how high-dose steroids move through the body

This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.

London

Hear when a new Hepatotoxicity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.